1 Table of Contents
1.1 List of Figures
1.2 List of Tables

2 Executive Summary
2.1 Executive Summary
2.2 Key Highlights
2.3 Key Events: South Korean Pharmaceutical News, 2014-2020
2.4 Key Events: South Korean Pharmaceutical Market
2.5 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.6 Key Events: Mergers and Acquisitions
2.7 Country Profile, South Korea, 2019

3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Drug Approvals
3.3 Pharmaceutical Market - Exports
3.4 Pharmaceutical Market - Imports
3.5 Pharmaceutical Supply Channels, South Korea
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, South Korea
3.7 COVID-19 Epidemiology, South Korea
3.8 Government Response to Mitigate COVID-19
3.9 COVID-19 Impact and Developments in Healthcare Market, South Korea
3.10 Pharmaceutical Market - Major Players

4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Major Segments
4.3 Medical Device Market - Major Players

5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers

6 Deal Analysis
6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, South Korea 2019-2020
6.2 Deal Analysis: M&A, VF and PE Deals, Medical Devices, South Korea 2019-2020

7 HealthTech Landscape
7.1 HealthTech Landscape, South Korea
7.2 Digital Statistics, South Korea
7.3 Adoption of Technology in Healthcare, South Korea
7.4 HealthTech Deals Landscape, South Korea
7.5 Key HealthTech Deals, South Korea
7.6 Regulatory Scenario Covering Use of Technology in Healthcare
7.5 HealthTech Landscape- South Korea- Benefits and Risks

8 Market Access
8.1 Overview of Healthcare System, South Korea
8.2 Reimbursement Process (Drug and Medical Device), South Korea
8.3 Overview of Insurance Providers (Public and Private), South Korea
8.4 Healthcare Spending and Health Price Index, South Korea
8.5 Pricing Policies, South Korea
8.6 Regulatory Landscape, South Korea
8.6.1 Market Authorization for Pharmaceutical Drugs, South Korea
8.6.2 Market Authorization for Generic Drugs, South Korea
8.6.3 Market Authorization for OTC Drugs, South Korea
8.6.4 Market Authorization for Biosimilars, South Korea
8.6.5 Market Authorization for Medical Devices, South Korea
8.6.6 Licensing Process for Pharmaceutical Exports and Imports
8.6.7 Intellectual Property Rights, Patent, South Korea
8.6.8 Clinical Trial Regulations, South Korea
8.6.9 Pharmaceutical Clinical Trials Landscape, South Korea
8.6.10 Medical Device Clinical Trials Landscape, South Korea
8.6.11 Pharmaceutical Advertising Regulations, South Korea
8.6.12 Pharmacy Regulations, South Korea
8.6.13 Labeling and Packaging Regulations, South Korea

9 Country Healthcare Landscape
9.1 Major Healthcare Policies, South Korea
9.2 Healthcare Facilities, South Korea
9.3 Healthcare Parameters, South Korea
9.4 Life Expectancy and Immunization Rate, South Korea
9.5 Environmental Health, South Korea
9.6 Healthcare Personnel, South Korea
9.7 Disease Burden, South Korea
9.8 Healthcare Expenditure

10 Trade Associations, South Korea

11 Trade Fairs, South Korea

12 Opportunities and Challenges

13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.1.4 Expert Panel
13.2 Bibliography
13.3 Contact Us
13.4 Disclaimer

List of Tables
Table 1: Approved Biologics, South Korea, 2018
Table 2: Approved Biosimilars, South Korea, 2012-2018
Table 3: COVID-19 Indicators (Number of cases), Global and South Korea, 2020
Table 4: Major COVID 19 Pipeline Drugs, South Korea, 2020
Table 5: COVID-19 Clinical Trials, South Korea, 2020
Table 6: COVID-19 Diagnostic Equipment, South Korea, 2020
Table 7: Hospital Supplies Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2016
Table 8: Diagnostic Imaging Devices Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 9: Dental Devices Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 10: Ophthalmic Devices Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 11: General Surgery Devices Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 12: National Insurance Contribution Rates, South Korea, 2019
Table 13: Long-Term Care Insurance System vs Previous Elderly Benefit Service System, South Korea, 2018
Table 14: Medical Products Fees, South Korea, 2018
Table 15: Medical Device Classification, South Korea, 2017
Table 16: Patent Fees, South Korea, 2020
Table 17: Trademark Fees, South Korea, 2018
Table 18: Drug Container and Package Information, South Korea, 2017
Table 19: Package Insert Information, South Korea, 2017
Table 20: Trade Fairs, 2020

List of Figures
Figure 1: Pharmaceutical Market, South Korea, Revenue ($B), 2012-2018
Figure 2: Medical Device Market, South Korea, Revenue ($B), 2015-2020
Figure 3: Country Profile, South Korea, 2019
Figure 4: Pharmaceutical Market, South Korea, Revenue ($B), 2011-2018
Figure 5: Pharmaceutical Market, South Korea, Revenue Forecast ($B), 2019-2025
Figure 6: Drug Approvals and Notifications (number), South Korea, 2010-2018
Figure 7: Drug Approvals by Therapeutic Class, South Korea, 2018
Figure 8: Pharmaceutical Exports ($M), South Korea, 2010-2019
Figure 9: Top Export Partners, South Korea, 2019
Figure 10: Pharmaceutical Imports ($B), South Korea, 2010-2019
Figure 11: Top Import Partners, South Korea, 2019
Figure 12: Process of Assigning KD Code, South Korea, 2018
Figure 13: Drug Supply and Report Process of Drug Transaction Records, South Korea, 2016
Figure 14: Biopharmaceutical Market, South Korea, Revenue ($B), 2010-2018
Figure 15: Top 5 Biopharmaceuticals (by production amount ton), South Korea, 2017
Figure 16: Major Bio - Health Clusters, South Korea, 2019
Figure 17: OTC Market, South Korea, Major Categories ($M), 2019
Figure 18: OTC Market, South Korea, Revenue ($M), 2010-2019
Figure 19: Therapeutic Area by Sales per Capita ($/person), South Korea, 2018
Figure 20: Therapeutic Area by Pharmaceutical Consumption (DDD/1,000 person/day), South Korea, 2018
Figure 21: COVID-19 (Number of cases), South Korea, 2020
Figure 22: COVID-19 (Number of deaths), South Korea, 2020
Figure 23: COVID-19 Monetary Stimulus, South Korea, 2020
Figure 24: COVID-19 Fiscal Stimulus, South Korea, 2020
Figure 25: Pharmaceutical Market, Major Players, 2018
Figure 26: Medical Device Market, South Korea, Revenue ($B), 2015-2020
Figure 27: Medical Device Market, South Korea, Revenue Forecast ($B), 2021-2025
Figure 28: Medical Devices Market, Major Segments (%), South Korea, 2019
Figure 29: Hospital Supplies Market, South Korea, Revenue ($M), 2015-2022
Figure 30: Hospital Supplies Market, South Korea, Market Share of Major Players (%), 2016
Figure 31: Diagnostic Imaging Devices Market, South Korea, Revenue ($M), 2015-2022
Figure 32: Diagnostic Imaging Devices Market, South Korea, Market Share of Major Players (%), 2019
Figure 33: Dental Devices Market, South Korea, Revenue ($B), 2015-2022
Figure 34: Dental Devices Market, South Korea, Market Share of Major Players (%), 2018
Figure 35: Ophthalmic Devices Market, South Korea, Revenue ($M), 2015-2022
Figure 36: Ophthalmic Devices Market, South Korea, Market Share of Major Players (%), 2015
Figure 37: General Surgery Devices Market, South Korea, Revenue ($M), 2015-2022
Figure 38: General Surgery Devices Market, South Korea, Market Share of Major Companies (%), 2019
Figure 39: Diagnostic Market, South Korea, Revenue ($M), 2015-2020
Figure 40: Diagnostic Market, South Korea, Revenue ($M), 2021-2025
Figure 41: Medical Device Market, South Korea, Revenue ($B) of Major Companies, 2019
Figure 42: Deal Value and Deal Count, Pharmaceutical Market, South Korea, 2019-2020
Figure 43: Deal Value and Deal Count Quarterly, Pharmaceutical Market, South Korea, 2019-2020
Figure 44: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, South Korea, 2019-2020
Figure 45: Top Therapy Areas by Deal Value, Pharmaceutical Market, South Korea, 2019-2020